PK/PD bioanalysis of biological medicines during development
PK/PD bioanalysis helps determine what happens to a biological medicine in the body and how its exposure relates to the…
Potency assays in biological products and their importance in quality control
Potency assays in biological products are essential tools for evaluating the biological activity of medicines such as recombinant proteins, monoclonal…
Protein aggregates in biological medicines and their impact on quality
Biological medicines have transformed the treatment of numerous diseases thanks to their ability to act on specific therapeutic targets. However,…
Peptide Mapping: What it is and why it is key for biologics
Biological medicines present analytical challenges that are very different from those of conventional drugs. Therapeutic proteins and monoclonal antibodies have…
Characterization of Therapeutic Proteins Using High-Resolution Mass Spectrometry
Therapeutic protein characterization is a fundamental stage in the development and control of biopharmaceutical products. Monoclonal antibodies, recombinant proteins, enzymes,…
A new identity for a company with greater capabilities
Netpharmalab updates its visual identity to reflect its growth, expanded capabilities, the integration of Docuchem and its consolidation as part…
Dissolution Problems: The silent challenge behind many successful reformulations
Modern pharmaceutical development is no longer focused solely on discovering new molecules. Increasingly, companies are investing significant resources in reformulating…
The boom in complex generics is reshaping pharmaceutical development needs
The pharmaceutical industry is undergoing a significant transformation driven by the growth of complex generics, a category of medicines that…
Chemical reverse engineering for identifying unknown impurities and solving complex problems
In sectors such as pharmaceuticals, chemicals, cosmetics, and food production, the appearance of unexpected product failures can lead to significant…
USP 661.2: The Growth Driver of Extractables and Leachables
Impact of USP 661.2 on the Pharmaceutical Industry The pharmaceutical and biotechnology sector is undergoing a key transformation driven by…

